To explore the potential mechanism of ATO resistance, we previously developed an ATO-resistant CML cell line (K-562) cells; moreover, we identified that UNC13B was highly expressed in such cells via gene chip screening. The gene discussed is UNC13B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.